These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21322764)

  • 1. Therapeutic potential of vaccines for Alzheimer's disease.
    Shah S; Federoff HJ
    Immunotherapy; 2011 Feb; 3(2):287-98. PubMed ID: 21322764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].
    Kuzuhara S
    Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
    Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
    Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis.
    Boche D; Denham N; Holmes C; Nicoll JA
    Acta Neuropathol; 2010 Sep; 120(3):369-84. PubMed ID: 20632020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of anti-Abeta vaccination as a promising therapy for Alzheimer's disease.
    Okura Y; Matsumoto Y
    Drug News Perspect; 2007; 20(6):379-86. PubMed ID: 17925892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of amyloid beta-peptide accumulation in Tg2576 transgenic mice by oral vaccination.
    Ishii-Katsuno R; Nakajima A; Katsuno T; Nojima J; Futai E; Sasagawa N; Yoshida T; Watanabe Y; Ishiura S
    Biochem Biophys Res Commun; 2010 Sep; 399(4):593-9. PubMed ID: 20682291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy as treatment for Alzheimer's disease.
    Hawkes CA; McLaurin J
    Expert Rev Neurother; 2007 Nov; 7(11):1535-48. PubMed ID: 17997702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearing tau pathology with Abeta immunotherapy--reversible and irreversible stages revealed.
    Hutton M; McGowan E
    Neuron; 2004 Aug; 43(3):293-4. PubMed ID: 15294135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aβ immunotherapy for Alzheimer's disease].
    Sakai K; Yamada M
    Brain Nerve; 2013 Apr; 65(4):461-8. PubMed ID: 23568994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Abeta vaccine therapy for Alzheimer's disease].
    Hara H
    Rinsho Shinkeigaku; 2005 Nov; 45(11):867-9. PubMed ID: 16447748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Abeta: The good, the bad, and the unforeseen.
    Broytman O; Malter JS
    J Neurosci Res; 2004 Feb; 75(3):301-6. PubMed ID: 14743443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer vaccine: amyloid-beta on trial.
    Robinson SR; Bishop GM; Münch G
    Bioessays; 2003 Mar; 25(3):283-8. PubMed ID: 12596233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin and Alzheimer's disease immunotherapy.
    Solomon B
    Curr Opin Mol Ther; 2007 Feb; 9(1):79-85. PubMed ID: 17330405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Clinical trials in Alzheimer's disease': immunotherapy approaches.
    Delrieu J; Ousset PJ; Caillaud C; Vellas B
    J Neurochem; 2012 Jan; 120 Suppl 1():186-193. PubMed ID: 21883222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current progress in beta-amyloid immunotherapy.
    Schenk D; Hagen M; Seubert P
    Curr Opin Immunol; 2004 Oct; 16(5):599-606. PubMed ID: 15342006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease.
    Panza F; Frisardi V; Imbimbo BP; D'Onofrio G; Pietrarossa G; Seripa D; Pilotto A; Solfrizzi V
    Immunotherapy; 2010 Nov; 2(6):767-82. PubMed ID: 21091109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The lesions of Alzheimer's disease: which therapeutic perspectives?].
    Duyckaerts C; Perruchini C; Lebouvier T; Potier MC
    Bull Acad Natl Med; 2008 Feb; 192(2):303-18; discussion 318-21. PubMed ID: 18819685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A beta immunotherapy: Lessons learned for potential treatment of Alzheimer's disease.
    Schenk DB; Seubert P; Grundman M; Black R
    Neurodegener Dis; 2005; 2(5):255-60. PubMed ID: 16909006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic immunotherapy of Alzheimer's disease using recombinant amyloid-β B-cell epitope chimeric protein as subunit vaccine.
    Yu YZ; Xu Q
    Hum Vaccin Immunother; 2016 Nov; 12(11):2801-2804. PubMed ID: 27379885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.